FDA Inspection
Newark Beth Israel Medical Center IRBNewark Beth Israel Medical Center IRB – FDA Inspection, Nov 5, 2013
Record Details
This FDA Inspection record concerns Newark Beth Israel Medical Center IRB, with an inspection on November 5, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 5, 2013
- Product Type
- Drugs
View Company Profile
ID · 967e805d-6e51-4ac3-af80-4d5768d94ace
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 855504
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 56.108(a)(1)Initial and continuing reviews
- 21 CFR 56.108(b)(2)Prompt reporting of noncompliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Newark Beth Israel Medical Center IRB
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 2, 2025 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| March 23, 2017 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Newark Beth Israel Medical Center IRB
- FDA Inspection 1275656 - 2025-07-02
- FDA Inspection 1007625 - 2017-03-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.